Familial dyslipidemias represent a classification system within clinical biochemistry defined by specific enzymatic deficiencies or overproduction mechanisms that disrupt normal lipid transport pathways. The core theoretical principle involves distinct defects in lipoprotein metabolism—such as Lipoprotein Lipase (LPL), LDL receptor, Apo E, and MTP deficiencies—which directly result in characteristic pathologies including hypertriglyceridemia-induced pancreatitis or cholesterol accumulation manifesting as xanthomas. This domain categorizes lipid disorders into specific phenotypes based on the unique biochemical intermediates that accumulate due to these genetic defects, establishing a deterministic relationship between molecular mechanism, circulating particle composition, and clinical presentation.
Familial dyslipidemias represent a classification system within clinical biochemistry defined by specific enzymatic deficiencies or overproduction mechanisms that disrupt normal lipid transport pathw…